BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26808689)

  • 21. Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation.
    Hackler EA; Byun NE; Jones CK; Williams JM; Baheza R; Sengupta S; Grier MD; Avison M; Conn PJ; Gore JC
    Neuroscience; 2010 Jun; 168(1):209-18. PubMed ID: 20350588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity.
    Vardigan JD; Lange HS; Tye SJ; Fox SV; Smith SM; Uslaner JM
    Psychopharmacology (Berl); 2016 Jul; 233(13):2441-50. PubMed ID: 27117142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
    Amitai N; Markou A
    Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat.
    Johnson RG; Stevens KE; Rose GM
    J Pharmacol Exp Ther; 1998 May; 285(2):643-50. PubMed ID: 9580608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
    Swanson CJ; Schoepp DD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic glutamate receptors subtype 5 are necessary for the enhancement of auditory evoked potentials in the lateral nucleus of the amygdala by tetanic stimulation of the auditory thalamus.
    Zheng J; Wu X; Li L
    Neuroscience; 2008 Mar; 152(1):254-64. PubMed ID: 18065158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asenapine effects in animal models of psychosis and cognitive function.
    Marston HM; Young JW; Martin FD; Serpa KA; Moore CL; Wong EH; Gold L; Meltzer LT; Azar MR; Geyer MA; Shahid M
    Psychopharmacology (Berl); 2009 Nov; 206(4):699-714. PubMed ID: 19462162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptors.
    Monn JA; Massey SM; Valli MJ; Henry SS; Stephenson GA; Bures M; Hérin M; Catlow J; Giera D; Wright RA; Johnson BG; Andis SL; Kingston A; Schoepp DD
    J Med Chem; 2007 Jan; 50(2):233-40. PubMed ID: 17228865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
    Schlumberger C; Pietraszek M; Gravius A; Klein KU; Greco S; Morè L; Danysz W
    Eur J Pharmacol; 2009 Nov; 623(1-3):73-83. PubMed ID: 19765575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
    de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
    Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat.
    Joy B; McMahon RP; Shepard PD
    Psychopharmacology (Berl); 2004 Jul; 174(2):274-82. PubMed ID: 14726994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aberrant gamma frequency oscillations on prepulse inhibition.
    Jones NC; Anderson P; Rind G; Sullivan C; van den Buuse M; O'Brien TJ
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1671-81. PubMed ID: 24832766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.
    Xing B; Han G; Wang MJ; Snyder MA; Gao WJ
    Neuropharmacology; 2018 Jul; 137():359-371. PubMed ID: 29793154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
    Schlumberger C; Schäfer D; Barberi C; Morè L; Nagel J; Pietraszek M; Schmidt WJ; Danysz W
    Behav Pharmacol; 2009 Feb; 20(1):56-66. PubMed ID: 19179851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
    Patil ST; Zhang L; Martenyi F; Lowe SL; Jackson KA; Andreev BV; Avedisova AS; Bardenstein LM; Gurovich IY; Morozova MA; Mosolov SN; Neznanov NG; Reznik AM; Smulevich AB; Tochilov VA; Johnson BG; Monn JA; Schoepp DD
    Nat Med; 2007 Sep; 13(9):1102-7. PubMed ID: 17767166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP).
    Javitt DC; Jayachandra M; Lindsley RW; Specht CM; Schroeder CE
    Clin Neurophysiol; 2000 May; 111(5):833-6. PubMed ID: 10802454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine improves deficient sensory inhibition in DBA/2 mice.
    Simosky JK; Freedman R; Stevens KE
    Brain Res; 2008 Oct; 1233():129-36. PubMed ID: 18687314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex.
    Dissanayake DW; Zachariou M; Marsden CA; Mason R
    Brain Res; 2009 Nov; 1298():153-60. PubMed ID: 19699183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.